← Holders
Madison Avenue Partners, LP
What Madison Avenue Partners, LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1801265 · Filed Nov 16, 2026
- Positions
- 26
- Reported value
- $2.5B
- Opened
- 5
- Closed
- 4
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$1.7B20 positions
- Dec 31, 2025$2.3B23 positions
- Mar 31, 2026$2.3B27 positions
- Jun 30, 2026$2.3B25 positions
- Sep 30, 2026$2.5B26 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
GHCGraham Holdings Co | 246.4K | ±0% | $279.5M | 11.1% |
CSGPCoStar Group, Inc. | 9.9M | New | $271.4M | 10.8% |
MBGLMobility Global Inc. | 11.5M | New | $196.6M | 7.8% |
MKLMarkel Group Inc. | 112.3K | ±0% | $192.4M | 7.6% |
INDVSupernus, Inc. | 4.9M | +68.8% | $173.9M | 6.9% |
CPNGCoupang, Inc. | 12.3M | −1.6% | $170M | 6.7% |
MICCMagnum Ice Cream Co N.V. | 8.5M | −21.6% | $151.8M | 6% |
HONAHoneywell Aerospace Inc. | 818.3K | New | $126.8M | 5% |
INVHInvitation Homes Inc. | 4.7M | −43.6% | $123.8M | 4.9% |
STAAStaar Surgical Co | 4.9M | +17.2% | $110.6M | 4.4% |
LKFTLakefront Biotherapeutics NV | 3.5M | +2.0% | $104.3M | 4.1% |
SOLSSolstice Advanced Materials Inc. | 1.5M | New | $82.9M | 3.3% |
OCTVOctave Intelligence plc | 4.4M | +3.0% | $82.2M | 3.3% |
GMEDGlobus Medical Inc | 936.5K | +0.1% | $70.1M | 2.8% |
STGWStagwell Inc | 8M | ±0% | $65.2M | 2.6% |
PRIMPrimoris Services Corp | 776.3K | +68.0% | $57.8M | 2.3% |
SANMSanmina Corp | 216.3K | +14.9% | $46.5M | 1.8% |
BTIBritish American Tobacco p.l.c. | 823.3K | −21.1% | $44.8M | 1.8% |
SOLVSolventum Corp | 476.3K | −72.6% | $42M | 1.7% |
RAREUltragenyx Pharmaceutical Inc. | 1.7M | New | $25.6M | 1% |
AIVApartment Investment & Management Co | 12.4M | ±0% | $24.5M | 1% |
TPBTurning Point Brands, Inc. | 373.4K | +50.7% | $21.9M | 0.9% |
ADArray Digital Infrastructure, Inc. | 644.9K | −41.9% | $21.7M | 0.9% |
MNROMonro, Inc. | 1.3M | +1,255.9% | $18.2M | 0.7% |
KROSKeros Therapeutics, Inc. | 626.6K | ±0% | $7.1M | 0.3% |
MAGNMagnera Corp | 618K | −52.5% | $7M | 0.3% |